Michael Taylor

Michael Taylor is the Lead Portfolio Manager at Simplify Asset Management, where he manages the Simplify Health Care ETF (PINK), the first 100% pro bono ETF with all net profits donated to the Susan G. Komen foundation. His primary focus is on the U.S. healthcare sector, investing across biotech, medical technology (MedTech), gene therapy, and innovative health care companies spanning all market capitalizations. Taylor emphasizes exposure to high-growth healthcare companies with strong R&D, patent protection, new product innovation, and superior corporate governance, seeking to generate long-term capital appreciation and alpha relative to healthcare benchmarks.

Prior to joining Simplify in 2021, Taylor held senior roles as Portfolio Manager at Citadel LLC and Millennium, overseeing long/short healthcare equity portfolios often in excess of $1 billion. He is the founder and Managing Director of Critical Mass Partners LLC, and began his investment career as Head of Healthcare at OppenheimerFunds. Taylor is recognized for building top-performing healthcare funds and has over two decades of experience managing complex, hedged, and factor-neutral strategies in the healthcare space.

Taylor’s academic credentials include an MBA in Finance from the University of Rochester’s Simon Business School, an MS in Biotechnology from Johns Hopkins University, and a BS in Biology from Gettysburg College. His unique background as both a scientist and an investor underpins his expertise in evaluating biotechnology and pharmaceutical companies, bringing scientific rigor and deep industry knowledge to healthcare investing.